FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.

ABSTRACT:

SUBMITTER: Jia Y 

PROVIDER: S-EPMC10244167 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature